What is Median Technologies?
Median Technologies, founded in 2002 and headquartered in France, is a key player in the medical technology landscape. The company specializes in providing innovative imaging solutions and services designed to advance healthcare outcomes. Their offerings extend to delivering critical insights into novel therapies and treatment strategies, positioning them at the forefront of medical diagnostics and therapeutic development. The consistent flow of capital suggests strong market confidence in their technological advancements and business model.
How much funding has Median Technologies raised?
Median Technologies has raised a total of $53.1M across 2 funding rounds:
Other Financing Round
$9.4M
Debt
$43.7M
Other Financing Round (2023): $9.4M with participation from European Investment Bank
Debt (2025): $43.7M led by European Investment Bank
Key Investors in Median Technologies
European Investment Bank
Established in 1958 and headquartered in Luxembourg, European Investment Bank (EIB) is the European Union's nonprofit long-term lending and finance institution. Their involvement suggests a focus on significant, potentially EU-aligned, strategic projects.
What's next for Median Technologies?
With a substantial total funding amount of $53.1M and a recent major strategic investment of $43.7M, Median Technologies is well-positioned for accelerated growth and innovation. The company's focus on imaging solutions and therapeutic insights indicates a strategic direction towards enhancing patient care and medical research. Future endeavors will likely involve expanding their technological capabilities, broadening market reach, and potentially forging new partnerships to further solidify their position in the competitive healthcare sector. The significant debt financing also suggests a strategy focused on scaling operations and infrastructure.
See full Median Technologies company page
